These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35512816)

  • 1. One-third of patients with lupus nephritis classified as complete responders continue to accrue progressive renal damage despite resolution of proteinuria.
    Weeding E; Fava A; Magder L; Goldman D; Petri M
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35512816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
    Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
    Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study.
    Karlsson L; Zickert A; Svenungsson E; Schmidt-Mende J; Faustini F; Gunnarsson I
    Clin Rheumatol; 2023 Nov; 42(11):2981-2986. PubMed ID: 37439924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.
    Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M
    Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    Gatto M; Saccon F; Andreoli L; Bartoloni E; Benvenuti F; Bortoluzzi A; Bozzolo E; Brunetta E; Canti V; Cardinaletti P; Ceccarelli F; Ciccia F; Conti F; De Marchi G; de Paulis A; De Vita S; Emmi G; Faggioli P; Fasano S; Fredi M; Gabrielli A; Gasparotto M; Gerli R; Gerosa M; Govoni M; Gremese E; Laria A; Larosa M; Mosca M; Orsolini G; Pazzola G; Petricca L; Ramirez GA; Regola F; Rossi FW; Rossini M; Salvarani C; Scarpato S; Tani C; Tincani A; Ubiali T; Urban ML; Zen M; Doria A; Iaccarino L
    J Autoimmun; 2021 Nov; 124():102729. PubMed ID: 34600347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients.
    Al Arfaj AS; Khalil N
    Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):154-160. PubMed ID: 38146725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience.
    Duran E; Yıldırım T; Taghiyeva A; Bilgin E; Arıcı M; Sağlam EA; Özen S; Üner M; Erdem Y; Kalyoncu U; Ertenli AI
    Lupus; 2022 Aug; 31(9):1147-1156. PubMed ID: 35658643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV.
    Okabayashi Y; Tsuboi N; Haruhara K; Kanzaki G; Koike K; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Mod Rheumatol; 2020 Jan; 30(1):125-131. PubMed ID: 30557058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
    Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
    J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.
    Medina-Rosas J; Fung WA; Su J; Touma Z
    Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis.
    Zhang P; Yang X; Fang X; Xu C; Gao C; Xia Z
    Nephrology (Carlton); 2023 Sep; 28(9):485-494. PubMed ID: 37485575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
    Kim H; Kim T; Kim M; Lee HY; Kim Y; Kang MS; Kim J
    Lupus; 2020 Jul; 29(8):862-871. PubMed ID: 32408850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus.
    Kandane-Rathnayake R; Kent JR; Louthrenoo W; Luo SF; Wu YJ; Lateef A; Golder V; Sockalingam S; Navarra SA; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Lau CS; Hoi A; Nikpour M; Morand E
    Lupus; 2019 Dec; 28(14):1669-1677. PubMed ID: 31718467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.
    Smith EMD; Yin P; Jorgensen AL; Beresford MW;
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):14. PubMed ID: 29467038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation.
    Haridasan S; Rathi M; Sharma A; Nada R; Kumar S; Ramachandran R; Kohli HS
    Int J Rheum Dis; 2020 Aug; 23(9):1201-1209. PubMed ID: 32677761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renal outcomes of patients with non-proliferative lupus nephritis.
    Kang ES; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Korean J Intern Med; 2023 Sep; 38(5):769-776. PubMed ID: 37545141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
    Hsieh YP; Wen YK; Chen ML
    Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
    Rovin BH; Teng YKO; Ginzler EM; Arriens C; Caster DJ; Romero-Diaz J; Gibson K; Kaplan J; Lisk L; Navarra S; Parikh SV; Randhawa S; Solomons N; Huizinga RB
    Lancet; 2021 May; 397(10289):2070-2080. PubMed ID: 33971155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS; Kim S; Chin HJ
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function.
    Luo H; Zhou Y; Chen G; Ren Q; Zhao J; Ye W; Qin Y; Li X
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.